Lead Real Estate (LRE) : 4-month performance

 

 

 

• 2 months later

Arcutis Biotherapeutics (ARQT) : 4-year performance

 

Motus GI (MOTS): 6-year performance

 

Abivax (ABVX) began trading on the Nasdaq on 20 Oct 23

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. 

 

It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. 

• Sector: Healthcare
• Industry: Biotechnology
• Full Time Employees: 67
• Founded by Philippe Pouletty in 2003
• Headquartered in Paris, France
• https://www.abivax.com

==SEALSQ (LAES) : 7-month performance

SEALSQ Corp engages in the security of microcontrollers.  It serves smart energy, smart home, automotive EV charging, consumer IoT, aerospace and military telecommunications, industry, logistics, medical, and luxury sectors. 

SEALSQ Corp operates as a subsidiary of WISeKey International Holding AG.

• Sector: Technology
• Industry: Semiconductors
• Full Time Employees: 67
• Founded in 2022
• Headquartered in Cointrin, Switzerland. 
• https://www.sealsq.com

IPO: 22 May 23

Rent the Runway (RENT) : 2-year performance

Ticker: RENT 

IPO: 27 Oct 21

iQIYI (IQ) : 6-year performance

Ticker: IQ

 

BrightSpring Health Services files for an estimated $1 billion IPO

BrightSpring Health Services Inc. filed for a US initial public offering on the first business day of the New Year.

The home and community-based health-care services provider backed by KKR & Co. was planning to seek to raise $1 billion in an IPO, Bloomberg News reported in September. Tuesday’s filing with the US Securities and Exchange Commission doesn’t include proposed terms of the offering, which would be disclosed in a subsequent filing.

The company previously filed for an IPO in late 2021, but withdrew just over a year after its initial filing.

The Louisville, KY-based company was founded in 1974 and booked $8.4 billion in revenue for the 12 months ended September 30, 2023. It plans to list on the Nasdaq under the symbol BTSG. BrightSpring Health Services filed confidentially on August 28, 2023. Goldman Sachs, KKR, Jefferies, Morgan Stanley, UBS Investment Bank, BofA Securities, Guggenheim Securities, and Leerink Partners are the joint bookrunners on the deal. No pricing terms were disclosed.

Company Data

• Headquarters Louisville, KY, United States
• Founded 1974
• Employees 35,000
• Website  www.brightspringhealth.com